Goel Vet Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 08-07-2024
- Paid Up Capital ₹ 2.50 M
as on 08-07-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.50 Cr
as on 08-07-2024
- Revenue 26.15%
(FY 2022)
- Profit 21.20%
(FY 2022)
- Ebitda 131.96%
(FY 2022)
- Net Worth 61.57%
(FY 2022)
- Total Assets 42.81%
(FY 2022)
About Goel Vet Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹5.50 Cr.
Bhaskar Goel, Sushma Goel, Mradul Goel, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909RJ2017PTC058403
- Company No.
058403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Chittorgarh, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
What products or services does Goel Vet Pharma Private Limited offer?
Goel Vet Pharma Private Limited offers a wide range of products and services, including Pet Furniture & Products, Pet Grooming Tools, Animal Medicines & Health Care, Veterinary Medicines, Homeopathic Veterinary Medicines, Homeopathic Drugs, Animal Feed Supplement, Cattle Feed Supplement, Dog Medicines.
Who are the key members and board of directors at Goel Vet Pharma?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mradul Goel | Director | 24-Jun-2017 | Current |
Bhaskar Goel | Director | 24-Jun-2017 | Current |
Sushma Goel | Director | 24-Jun-2017 | Current |
Vikrant Goel | Director | 24-Jun-2017 | Current |
Financial Performance of Goel Vet Pharma.
Goel Vet Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.15% increase. The company also saw a substantial improvement in profitability, with a 21.2% increase in profit. The company's net worth Soared by an impressive increase of 61.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Goel Vet Pharma?
Unlock access to Goel Vet Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Homeonest India Private LimitedActive 18 years 7 months
Bhaskar Goel, Sushma Goel and 2 more are mutual person
- Homeonest Remedies Private LimitedActive 2 years 8 months
Bhaskar Goel, Mradul Goel and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 25 Feb 2021 | ₹4.50 Cr | Open |
Others Creation Date: 28 Feb 2018 | ₹1.00 Cr | Open |
How Many Employees Work at Goel Vet Pharma?
Goel Vet Pharma has a workforce of 111 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goel Vet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goel Vet Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.